AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
24,559,929
Share change
+985,949
Total reported value
$767,585,500
Price per share
$31.25
Number of holders
86
Value change
+$32,219,505
Number of buys
52
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q4 2017

As of 31 Dec 2017, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 86 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,559,929 shares. The largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Versant Venture Management, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Redmile Group, LLC, Vanguard Group Inc, JENNISON ASSOCIATES LLC, and PERCEPTIVE ADVISORS LLC. This page lists 86 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.